BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 18436805)

  • 1. Alpha2-antiplasmin is a critical regulator of angiotensin II-mediated vascular remodeling.
    Hou Y; Okada K; Okamoto C; Ueshima S; Matsuo O
    Arterioscler Thromb Vasc Biol; 2008 Jul; 28(7):1257-62. PubMed ID: 18436805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aldosterone and not plasminogen activator inhibitor-1 is a critical mediator of early angiotensin II/NG-nitro-L-arginine methyl ester-induced myocardial injury.
    Oestreicher EM; Martinez-Vasquez D; Stone JR; Jonasson L; Roubsanthisuk W; Mukasa K; Adler GK
    Circulation; 2003 Nov; 108(20):2517-23. PubMed ID: 14581407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting the calpain/calpastatin system as a new strategy to prevent cardiovascular remodeling in angiotensin II-induced hypertension.
    Letavernier E; Perez J; Bellocq A; Mesnard L; de Castro Keller A; Haymann JP; Baud L
    Circ Res; 2008 Mar; 102(6):720-8. PubMed ID: 18258859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological inhibition and genetic deficiency of plasminogen activator inhibitor-1 attenuates angiotensin II/salt-induced aortic remodeling.
    Weisberg AD; Albornoz F; Griffin JP; Crandall DL; Elokdah H; Fogo AB; Vaughan DE; Brown NJ
    Arterioscler Thromb Vasc Biol; 2005 Feb; 25(2):365-71. PubMed ID: 15576638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-talk between aldosterone and angiotensin II in vascular smooth muscle cell senescence.
    Min LJ; Mogi M; Iwanami J; Li JM; Sakata A; Fujita T; Tsukuda K; Iwai M; Horiuchi M
    Cardiovasc Res; 2007 Dec; 76(3):506-16. PubMed ID: 17706954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IRF3 regulates cardiac fibrosis but not hypertrophy in mice during angiotensin II-induced hypertension.
    Tsushima K; Osawa T; Yanai H; Nakajima A; Takaoka A; Manabe I; Ohba Y; Imai Y; Taniguchi T; Nagai R
    FASEB J; 2011 May; 25(5):1531-43. PubMed ID: 21266535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin II-induced p53-dependent cardiac apoptotic cell death: its prevention by metallothionein.
    Liu Q; Wang G; Zhou G; Tan Y; Wang X; Wei W; Liu L; Xue W; Feng W; Cai L
    Toxicol Lett; 2009 Dec; 191(2-3):314-20. PubMed ID: 19808082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small artery remodeling and erythrocyte deformability in L-NAME-induced hypertension: role of transglutaminases.
    Pistea A; Bakker EN; Spaan JA; Hardeman MR; van Rooijen N; VanBavel E
    J Vasc Res; 2008; 45(1):10-8. PubMed ID: 17898543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin II induces premature senescence of vascular smooth muscle cells and accelerates the development of atherosclerosis via a p21-dependent pathway.
    Kunieda T; Minamino T; Nishi J; Tateno K; Oyama T; Katsuno T; Miyauchi H; Orimo M; Okada S; Takamura M; Nagai T; Kaneko S; Komuro I
    Circulation; 2006 Aug; 114(9):953-60. PubMed ID: 16908765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pitavastatin, an HMG-CoA reductase inhibitor, exerts eNOS-independent protective actions against angiotensin II induced cardiovascular remodeling and renal insufficiency.
    Yagi S; Aihara K; Ikeda Y; Sumitomo Y; Yoshida S; Ise T; Iwase T; Ishikawa K; Azuma H; Akaike M; Matsumoto T
    Circ Res; 2008 Jan; 102(1):68-76. PubMed ID: 17967781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EGCG inhibits proliferation of cardiac fibroblasts in rats with cardiac hypertrophy.
    Sheng R; Gu ZL; Xie ML; Zhou WX; Guo CY
    Planta Med; 2009 Feb; 75(2):113-20. PubMed ID: 19096994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue type plasminogen activator facilitates NMDA-receptor-mediated retinal apoptosis through an independent fibrinolytic cascade.
    Kumada M; Niwa M; Hara A; Matsuno H; Mori H; Ueshima S; Matsuo O; Yamamoto T; Kozawa O
    Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1504-7. PubMed ID: 15790922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adiponectin protects against angiotensin II-induced cardiac fibrosis through activation of PPAR-alpha.
    Fujita K; Maeda N; Sonoda M; Ohashi K; Hibuse T; Nishizawa H; Nishida M; Hiuge A; Kurata A; Kihara S; Shimomura I; Funahashi T
    Arterioscler Thromb Vasc Biol; 2008 May; 28(5):863-70. PubMed ID: 18309113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of myosin light chain kinase expression by angiotensin II in hypertension.
    Han YJ; Hu WY; Piano M; de Lanerolle P
    Am J Hypertens; 2008 Aug; 21(8):860-5. PubMed ID: 18511912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metallothionein suppresses angiotensin II-induced nicotinamide adenine dinucleotide phosphate oxidase activation, nitrosative stress, apoptosis, and pathological remodeling in the diabetic heart.
    Zhou G; Li X; Hein DW; Xiang X; Marshall JP; Prabhu SD; Cai L
    J Am Coll Cardiol; 2008 Aug; 52(8):655-66. PubMed ID: 18702970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced angiotensin II production by renal mesangium is responsible for apoptosis/proliferation of endothelial and epithelial cells in a model of malignant hypertension.
    Efrati S; Berman S; Goldfinger N; Erez N; Averbukh Z; Golik A; Rotter V; Weissgarten J
    J Hypertens; 2007 May; 25(5):1041-52. PubMed ID: 17414669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasmin generation plays different roles in the formation and removal of arterial and venous thrombus in mice.
    Matsuno H; Kozawa O; Okada K; Ueshima S; Matsuo O; Uematsu T
    Thromb Haemost; 2002 Jan; 87(1):98-104. PubMed ID: 11848464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antagonist of C5aR prevents cardiac remodeling in angiotensin II-induced hypertension.
    Zhang C; Li Y; Wang C; Wu Y; Du J
    Am J Hypertens; 2014 Jun; 27(6):857-64. PubMed ID: 24419904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ets-1 is a critical regulator of Ang II-mediated vascular inflammation and remodeling.
    Zhan Y; Brown C; Maynard E; Anshelevich A; Ni W; Ho IC; Oettgen P
    J Clin Invest; 2005 Sep; 115(9):2508-16. PubMed ID: 16138193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ablation of angiotensin IV receptor attenuates hypofibrinolysis via PAI-1 downregulation and reduces occlusive arterial thrombosis.
    Numaguchi Y; Ishii M; Kubota R; Morita Y; Yamamoto K; Matsushita T; Okumura K; Murohara T
    Arterioscler Thromb Vasc Biol; 2009 Dec; 29(12):2102-8. PubMed ID: 19745198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.